While observed hypoglycemia rates and duration were similar in those treated with metformin and SU, hypoglycemia risk was strongly associated with glycemic control, and after adjusting for differences in HbA1c, the risk of hypoglycemia doubled and quintupled in those treated with SUs and insulin, respectively. The gene discussed is INS; the disease is Hypoglycemia.